The World Anti-Doping Agency (WADA) has published the Prohibited List 2022, which enters into force on 1 January 2022 and replaces all previous lists. The updates affect in particular the class of glucocorticoids and the substance salbutamol.

The WADA has made several modifications to the Prohibited List 2022 which have an impact on the doping status of various medications. These modifications include:

Glucocorticoids

From 1 January 2022, more stringent regulations will be introduced for glucocorticoids. In addition to oral and rectal administration, injections of all kind will also be prohibited in competition. Intravenous and intramuscular injections are already prohibited but from 1 January 2022, the intra-articular injection of glucocorticoids, for example, will also be banned.

The publication of the Prohibited List 2022 by Antidoping Switzerland at the end of November 2020 will provide further information and practical recommendations on the washout periods of glucocorticoids.

Salbutamol

As of 1 January 2022, a lower threshold dose and adjusted time intervals for salbutamol inhalation will apply. The maximum permitted dose for inhalation is now 600 micrograms of salbutamol within 8 hours in divided doses. As previously, the dose must not exceed 1600 micrograms in 24 hours.

The 2022 Prohibited List and an exhaustive list of all modifications is provided by the WADA.

Antidoping Switzerland reminds all athletes to check all medications with Global DRO (via website or Mobile App) before use.